SCHEMBL752042

SCHEMBL752042

CCCCOC(=O)N1CCCC1c1ncc(Br)[nH]1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.40
CYP2C9 P11712 3/20 0.40
KCNH2 Q12809 2/20 0.40
NR1I2 O75469 1/20 0.40
ABCB11 O95342 1/20 0.40
OPRK1 P41145 1/20 0.40
PRCP P42785 6/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
CYP1A2 P05177 2/20 0.38
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP2D6 P10635 1/20 0.36
HCRTR1 O43613 2/20 0.35
HCRTR2 O43614 2/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35
GCK P35557 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1759015 0.87 PRCP (0.40) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL571726 0.85 CYP3A4 (0.50) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL14966582 0.83 CYP3A4 (0.49) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL3389376 0.82 PRCP (0.45) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL1758861 0.82 L3MBTL1 (0.35) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL45250 0.81 UCHL1 (0.44) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL45280 0.81 UCHL1 (0.44) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL2711186 0.81 UCHL1 (0.44) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL8749971 0.80 PREP (0.50) L3MBTL1
SCHEMBL23247493 0.77 UCHL1 (0.41) CYP3A4CYP2C9KCNH2NR1I2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2850085-A1 ANTIVIRAL COMPOUNDS INHIBITORS OF HCV NS5B Gilead Pharmasset LLC (US) 2015-03-25 EP disclosed
WO-2013173488-A1 ANTIVIRAL COMPOUNDS INHIBITORS OF HCV NS5B GILEAD SCIENCES, INC. (US) 2013-11-21 WO disclosed
EP-2640719-A2 ANTIVIRAL COMPOUNDS Gilead Sciences, Inc. (US) 2013-09-25 EP disclosed
WO-2013052369-A1 NOVEL BENZIMIDAZOLE DERIVATIVES ENANTA PHARMACEUTICALS, INC. (US) 2013-04-11 WO disclosed
WO-2012068234-A2 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2012-05-24 WO disclosed
EP-2430014-A1 ANTIVIRAL COMPOUNDS Gilead Sciences, Inc. (US) 2012-03-21 EP disclosed
WO-2010132601-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2010-11-18 WO disclosed